[Skip to Content]
[Skip to Content Landing]
November 24, 1969

2-Amino-4-hydroxy-6-7-Dimethyltetrahydropteridine In Parkinson's Disease

Author Affiliations

Brookhaven National Laboratory Upton, NY

JAMA. 1969;210(8):1594. doi:10.1001/jama.1969.03160340202041

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor:—  The suggestion made by Dr. Stock is based on solid scientific fact. I am not aware, however, of a malabsorption syndrome (like combined sclerosis) operating in patients with Parkinson's syndrome. This point would be a good subject matter for investigation. The actual therapeutic trial of 2-amino-4-hydroxy -6- 7 - dimethyltetrahydropteridine in selected individuals with Parkinson's syndrome might also be warrented.